Degenerative Disc Disease and Chronic Low Back Pain

This study is investigating a new injectable medical device called the DiscSeal which targets degenerative disc disease. DiscSeal aims to provide low back pain relief by strengthening and stabilizing the structure of the spinal disc. This clinical trial seeks to evaluate the safety, tolerability and preliminary efficacy of the DiscSeal for management of low back pain.

There will be approximately 6 visits to our trial site in Hurstville over 6 months. There is no cost to participate in the trial. Travel expenses will be reimbursed to participants for each clinic visit attended.

Eligibility

• Male or female, 18 to 70 years old
• History of chronic low back pain for at least 6 months
• Has undergone at least 6 weeks of conservative pain management (e.g. physiotherapy, chiropractor, acupuncture, ultrasound, anti-inflammatory medications, spinal injections and radiofrequency)